The 85th Annual Meeting of the Japanese Cancer Association

Presenting Author/Lead Presenter (Required)

• Applicants cannot submit more than one paper for Symposia, Open Symposia, International Sessions, Oral sessions or Poster Presentations as a first (presenting) author. (excluding certain special symposia and award lectures).
• Fill in the first name and last/surname separately and only the first letter of each name is to be capitalized.

Institutions (Required)

Up to 15 institutions can be registered. Please refer to the "Abbreviations for affiliated institutions" list.
Please do not exceed 10 words.

JCA Membership Number

Those who reside outside of Japan and do not have Japanese citizenship may submit an abstract without becoming a member.
If not, please apply for membership.

• EN: https://www.cancer.or.jp/modules/en/index.php?content_id=14
• JP: https://www.cancer.or.jp/modules/about/index.php?content_id=16

Co-authors

Up to 15 co-authors can be registered.
Fill in the first name and last/surname separately, with only the initial letter of each name capitalized.

Presentation Style (Required)

Please select your desired presentation style.
The final decisions on your presentation style will be made by the Organizing Committee.
Please note that you may be assigned to present in Poster style even when you choose Oral style.

Application for Designated Symposia, Open Symposia, International Sessions or Special Symposium

If you apply for Designated Symposia, Open Symposia, International Sessions or Special Symposium, please select the session you wish to apply from the list.

Abstract category (Required)

Please select the appropriate categories up to your second choice from the list.
Additional subcategory selection may be required depending on the submission field.
Details of subcategories are provided below.

Abstracts are classified into Category I (Research field) and Category II (Specific tumors).
For abstracts applicable to both categories, authors are encouraged to select Category I as the first choice.

Encore Abstract

When you submit an encore abstract*, please keep to the following points in mind.

• Make it clear in your abstract that this is an encore submission.
• If there is an issue regarding copyright, it is the responsibility of the presenter to obtain permission.

If the copyright holder is a society or a publisher, it should be noted at the end of the abstract with the bibliographic and other information of the original abstract that it has been published with permission.

*Encore Abstract: a presentation in Japan that is similar or identical to one which has already been presented outside of Japan.

JCA Young Researcher Poster Award

The "JCA Young Researcher Poster Award" is an award for posters presented by a young researcher as the presenting author.
Abstracts that are applied for poster sessions are subject to review.

• Eligibility: the presenting author must be an undergraduate or graduate student as of April 1, 2026. There is no age limit.

Travel Grant

Please check out the details from here.

Title (Required)

The length of the title must be no more than 120 characters including spaces.

Abstract (Required)

The length of the abstract body must be no more than 1,200 characters including spaces.
Place the first letter on the left end without a space.
Please do not insert any tables or figures in the text box as they cannot be uploaded.

Keyword (Required)

Please select up to 2 keywords.
If corresponding keywords are not listed, please enter the appropriate one in "Keyword 3" and "0000" in the required field.

Ethical Guidelines (Declaration of Ethical Considerations for Research Abstracts)

The Japanese Cancer Association requires presenters to declare that their submitted abstracts have undergone appropriate ethical review in accordance with the applicable research ethics regulations.

Depending on the content of the abstracts, even if approval by authors' institutional review boards (IRB) or equivalent committees is deemed unnecessary, please refer to the "Ethical Guidelines" below and make a declaration where required.

Please note that abstracts may be rejected or not accepted if no ethical declaration is made or if appropriate institutional approval has not been obtained.

For terminology, please refer to the "Ethical Guidelines for Life Science and Medical Research Involving Human Subjects" (promulgated on March 23, 2021; partially revised on March 27, 2023) issued by Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare, and Ministry of Economy, Trade and Industry of Japan（https://www.mext.go.jp/content/20250325-mxt_life-000035486-01.pdf）. For details, please see the following:

Disclosure of Conflict of Interest (Required)

For the first (presenting) author and the principal investigator (*1), please declare the presence or absence of any conflicts of interest (COI) with companies, organizations, or other entities at the time of abstract submission. If any conflicts of interest exist, please specify the names of the relevant companies or organizations. For details, please refer to the page below.

The Japanese Cancer Association revised its Guidelines on Conflicts of Interest in April 2025. In addition to conflicts of interest directly related to the submitted abstract, the following items must also be declared:

• Conflicts of interest of the individual that are not related to the submitted abstract.
• All research funding related to the submitted abstract, regardless of amount, including public funds such as Grants-in-Aid for Scientific Research (KAKENHI) and AMED.

The COI of the first (presenting) author and the principal investigator must be registered in the abstract submission system.

If the first (presenting) author is not the principal investigator, the person submitting the abstract is responsible for confirming the principal investigator's COI and registering it accordingly. Please use the confirmation sheet provided here if necessary.

Please note that abstracts for which the principal investigator's COI declaration form has not been completed will not be eligible for peer review.

(*1) The term "principal investigator" generally corresponds to the Principal Investigator (PI) of the laboratory or the Corresponding Author when the study is submitted as an original research article.

Others (Required)

• Please check the box to agree that the copyright of the abstract belongs to the Japanese Cancer Association. If you do not agree, you will not be able to submit your abstract.
• At the 85th Annual Meeting of the Japanese Cancer Association, presentations will be posted on the official X, formerly Twitter,/Facebook and may be photographed for personal social media usage. Please clearly mark "DO NOT POST" on the slides and posters that you do not wish to be photographed or distributed. If not marked, please note that it may be posted in the social media.
• After closing of the meeting, the contents of the meeting will be streamed on-demand on the viewing site of the 85th Annual Meeting of the Japan Cancer Association. If you wish to decline on-demand streaming, please contact the organizing secretariat (pr_jca2026@c-linkage.co.jp) at the latest, 5 days after your presentation. If no particular request is made, as agreed when registering your abstract, we will stream your presentation on-demand.

Password (Required)

Create your password to view/update your abstract. Password is case-sensitive and must be composed of 6 to 8 characters.
You can correct and confirm your abstract at any time during the submission period with your submission number (given at the time of the abstract submission) and your password.
In order to prevent a third party from reading and misusing your information, we are unable to respond to inquiries about your password. If you forget it, you are requested to submit the abstract again.

A confirmation email will be sent to your contact email address immediately after registration is complete. If you do not receive a confirmation email, please check that you have entered your contact email address correctly, and check if it was not sent to your spam folder.

• Those who do not receive a confirmation email
  If you do not receive the confirmation email within 24 hours, please contact us.
  Please note that we do not take responsibility or liability for if you leave your registration email unconfirmed.
• For users of web-based email services (e.g., Gmail, Yahoo Mail):
  Emails from this Annual Meeting may be automatically filtered into your spam or junk folder.
  If you have not received an email, please check your spam or junk folder first.

Use of Special Characters

Please refrain from using characters such as α, β, γ as symbols (1-byte character), since they are automatically transformed into a, b, c, etc. Please make sure to use HTML tags.
In the title and main text of the abstract, superscript, subscript, italic face, bold face, and underline can be used provided the following html tags are inserted. Tags for superscript, subscript, italic face, bold face, underline, or line feed are, in order: <SUP> </SUP>, <SUB> </SUB>, <I> </I>, <B> </B>, <U> </U>, and <BR>. They must be written in 1-byte characters. Please refer to the registration page for more details.

Figures and tables are not permitted.

More Special Characters